|
|
Article: BSD Medical licenses rights to NIH non-invasive deep hyperthermia cancer therapy.(US National Institutes of Health)(Brief Article)
- Article from:
- BIOTECH Patent News
- Article date:
- February 1, 2002
CopyrightCOPYRIGHT 2002 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BSD Medical Corporation (Salt Lake City, UT; 1-801-972-5555) announced the successful integration of a powerful Siemens MRI system with its advanced deep phased-array microwave hyperthermia system, the BSD-2000/3D. The company further announced that it has acquired the rights under a patent license from the United States National Institutes of Health to bring this revolutionary technology to the United States. The novel coupling of these sophisticated but very different technologies was pursued and patented by the NIH because non-invasive treatment monitoring is considered a crowning goal of non-invasive deep hyperthermia cancer therapy. "The NIH patented the ...